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processing of information which are also affected by PD. For example,
active matching tasks have commonly been used for this purpose.
With this approach, a target limb is passively placed in a particular
position, and the test subject is then asked to voluntarily move the
opposite limb, in an attempt to either match the end position (or
mimic the movement path) of the target limb. A problem with thisIntroduction
The traditional view of Parkinson's disease PD as a pure motor
disorder has been challenged in recent years by observations that
some motor deﬁcits in PD could be at least partially due to
proprioceptive disturbances. These insights have thus far been
derived mainly from studies on upper limb control (Schneider et al.,
1987; Klockgether et al., 1995; Demirci et al., 1997; Zia et al., 2000;
Adamovich et al., 2001; Maschke et al., 2003; Byblow et al., 2003;
Keijsers et al., 2005). For this reason, the recent ﬁndings ofWright and
colleagues, published recently in Experimental Neurology (Wright
et al., 2010), provide a unique opportunity to investigate whether
abnormal kinaesthesia in PD extends to axial joints as well. Here, we
will discuss how these new results of Wright and colleagues extend
our current knowledge on how PD may inﬂuence kinaesthesia. We
will also review the pathophysiology underlying such kinaesthetic
changes, and discuss the evidence in support of a proprioceptive
contribution to balance deﬁcits seen in PD.
Kinaesthetic deﬁcits in Parkinson's disease
While there is now clear evidence that sensori-motor and visuo-
motor integration are inﬂuenced by PD (see e.g. Bronstein et al., 1990;
Waterston et al., 1993), the effect of PD on kinaesthesia alone is far
less clear. Kinaesthesia is commonly deﬁned as the ability to detect
joint motion or a change in position of a joint. While common views of
kinaesthesia rely primarily on outputs from spindles or joint
receptors, recent work has demonstrated that cutaneous receptors
also play a signiﬁcant role in signalling changes in joint motion and
position (Proske and Gandevia, 2009). Crucially, in order to isolate the
potential effects of PD on kinaesthesia, a subject's ability to accurately
detect motion (or a change in position) must be examined undern, Department of Neurology
Box 9101, 6500 HB Nijmegen,
).
 OA license.approach is that any errors could be attributed to deﬁcits in either
kinaesthesia or motor output of the actively moving limb (both of
which are inﬂuenced by PD). Such interpretational difﬁculties also
hamper movement recall tasks (Adamovich et al., 2001; Keijsers et al.,
2005) and tasks involving vibration (Khudados et al., 1999; Smiley-
Oyen et al., 2002; Valkovic et al., 2006), as they rely on the integrity of
both sensory and motor pathways. Likewise, any task involving visual
feedback of the limb, or visual targets to which the limb should be
matched (Adamovich et al., 2001; Keijsers et al., 2005), are not suited
to examine the effects of kinaesthesia alone, as they rely as much on
the subject's accurate perception and integration of visual cues, as
they are on kinaesthetic function.
Consequently, only those studies that have utilized passive move-
ments of the limbs canbe relied uponasmeasures of truekinaesthesia in
PD. There are a variety of different passive movement study designs in
the literature that have been used to compare kinaesthetic function
between PD patients and age-matched controls. For example, PD
patients and controls have been required to correctly indicate the
direction of a perceived movement following passive displacement of a
limb by the experimenter (Schneider et al., 1987; Maschke et al., 2003;
Konczak et al., 2007; Putzki et al., 2006). In some experiments, the time
required to detect a passive limb displacement is measured (Konczak
et al., 2007). In other designs, subjects are asked to discriminate the
temporal or magnitude difference between two distinct passive move-
ments of the same joint (Putzki et al., 2006; Fiorio et al., 2007), to
estimate the relative change in a limb position (Demirci et al., 1997; Zia
et al., 2002) or to discriminate relative differences in static end positions
of two bilateral joints that have been displaced passively by the
experimenter (Zia et al., 2000; O'Suilleabhain et al., 2001). Under all of
the above conditions, the muscles are quiescent, and vision is removed
to eliminate any confounding inﬂuences of PD-related deﬁcits in motor
control or visual dependence. In all these studies, PD patients
demonstrated abnormal kinaesthesia. Speciﬁcally, they consistently
underestimated the amplitude of joint motion, demonstrated poorer
accuracy and higher detection thresholds compared to healthy age-
matched controls.
There are three striking features of all studies that used passive
movements to compare kinaesthetic function between PD patients
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about a single joint. The second is that all studies of passive
movements in PD were restricted to joints in the upper limb, hand,
or face. This is understandable, because measuring kinaesthesia along
the body axis is technically much more difﬁcult compared to
assessment of the limbs or digits, which are much easier to
manipulate independently and bilaterally. Moreover, measuring
axial kinaesthesia is complicated by the fact that the threshold for
detecting trunk position decreases when a subject is supine,
compared to when the same subject is actively standing upright
(Jakobs et al., 1985). Subjects would therefore have to be tested while
standing, in order to properly judge the functional implications of any
axial kinaesthetic deﬁcits in patients with PD. And the third main
feature is that virtually all prior studies have been restricted to
patients who were tested after normal intake of their antiparkinson
medication, with the exception of one study of 17 patients who were
tested in both the ON and OFF state (O'Suilleabhain et al., 2001), and
one in which subjects were tested only in the OFF state (Fiorio et al.,
2007).
Axial kinaesthesia is impaired in Parkinson's disease
The recent study by Wright and colleagues (2010) therefore
represents a novel and important step forward in the study of
kinaesthesia in PD. In this study, an ‘axial twisting’ technique used
previously to examine axial hypertonicity in PD (Gurﬁnkel et al.,
2006; Wright et al., 2007) was modiﬁed to assess axial kinaesthesia
(Wright et al., 2010). Speciﬁcally, subjects stood unaided while their
axial segments were being passively twisted about the horizontal
plane by a torsional rotation device, at a very low constant rotational
velocity (1°/s). This type of rotation involves no imposed shifts in
body mass or changes in orientation of the body relative to gravity.
The outcome was quantitative, and consisted of the detection
threshold and directional accuracy of the hip relative to the feet
(this was termed ‘Hip Kinaesthesia’) and of the hip relative to the
shoulders (‘Trunk Kinaesthesia’). Patients were tested ﬁrst in a so-
called practically deﬁned OFF state (in the morning, at least 12 h after
intake of the last dose of medication), and then again during an ON
state, about 45 min after intake of the usual ﬁrst morning dose of
Parkinson medication. In total 12 PD patients and 14 age-matched
controls participated.
Results in these types of experiments are typically expressed as the
ability to determine the correct direction of motion, and the threshold
for detecting onset of motion. Both outcomes were abnormal in PD
patients: the accuracy in determining the direction of axial twisting
was reduced, while the thresholds for perception of axial twisting
were increased. This was present both at the level of the hip and trunk.
But the most fascinating observation was that, unexpectedly, these
abnormalities were most pronounced in patients during the ON state,
but much smaller during the OFF state. In other words, dopaminergic
medication – which is normally used to improve the symptoms of PD,
as it did in these patients – signiﬁcantly worsened axial kinaesthesia.
In fact, the extent to which axial kinaesthesia worsened between ON
and OFF states correlated with the degree of disease severity in the
OFF state. An additional, but less important, ﬁnding was that PD
subjects with disease onset on the left side of their body showed
signiﬁcantly higher axial thresholds than subjects with right-onset
PD.
As such, this study represents the ﬁrst to examine kinaesthesia
during axial movements. And by extension, this report is also likely
the ﬁrst to examine kinaesthesia involving simultaneous movements
of multiple joints. A further novel aspect is that this was likely the ﬁrst
study to examine kinaesthesia from a joint under normal functional
loading (i.e. during upright stance). Most other studies used a more
artiﬁcially test environment, where the limb that was being passively
moved was isolated, or supported by a manipulandum. Finally, thisstudy is only the second to ever systematically test the effect of
medication on PD-related kinaesthetic deﬁcits, and with unexpected
results.
Interpretational issues
Adverse effects of medication
Although unexpected, the ﬁnding that Parkinson medication
appeared to worsen kinaesthesia is actually consistent with other
published work. O'Suilleabhain and colleagues (2001) used passive
displacements of bilateral elbow joints to examine kinaesthesia in PD
patients in the ON and OFF state, and in age-matched controls. Similar
to the ﬁndings of Wright et al. (2010), this study reported abnormal
kinaesthesia in PD patients in the ON state compared to OFF state.
Comparisons with controls indicated that deﬁcits in kinaesthesiawere
restricted to PD patients in the ON state (Zia et al., 2002). These
observations are consistent with the majority of other studies that
found abnormal kinaesthesia in PD patients tested only in the ON state
(Demirci et al., 1997; Maschke et al., 2003; Konczak et al., 2007; Fiorio
et al., 2007; Zia et al., 2002).
How to interpret these ﬁndings? First, the medication effects
observed by Wright and colleagues (2010) do not appear to be caused
bymethodological ﬂaws, because patients were properly tested in both
medication states. The OFF state was properly deﬁned according to
international standards (Langston et al., 1992), i.e. more than 12 h after
intake of the last dose of medication. It may take additional time – days
or even weeks – to completely eliminate all medication effects, so
formally speaking,medication effects during theOFF state as tested here
cannot be excluded. However, taking patients off their medication for
longer periods of time is ethically not justiﬁable. The ON state was
deﬁned asa subjective response to thenormalmedicationdose, andwas
accompanied by an objectively documented improvement in clinical
scores. Again, this is probably sufﬁcient, although ideally subjects should
have been tested after an individually tailored supramaximal medica-
tion dose, to ensure an optimal ON state, and also to avoid that patients
gradually turned OFF again during the experiment (Visser et al., 2008a,
2008b). But it is unlikely that such smaller medication effects can
explain the ﬁndings by Wright and colleagues (2010).
This leaves open two possible explanations: either medication had
direct adverse effects on kinaesthesia, or medication affected
kinaesthesia indirectly, via an effect on other symptoms of PD.
Dopaminergic medication is known to have adverse motor effects, in
particular in advanced disease stages where patients can suffer from
response ﬂuctuations and peak-dose dyskinesias. In fact, some have
even proposed that the drug-induced dyskinesias may reﬂect move-
ments generated purposefully by the CNS to compensate for abnormal
kinaesthesia in the ON state (Zia et al., 2002). There is some evidence
to support direct dopaminergic medication effects on sensory afferent
pathways in PD. For example, studies have shown abnormal reduction
of short latency afferent inhibition on the motor cortex in PD patients
in the ON compared to OFF state (Sailer et al., 2003).
There is also the possibility that medication affects kinaesthesia
indirectly, via an effect on other symptoms of PD. For example, in the
case of Wright et al. (2010), medication may have offered a partial
correction of the patient's stooped posture, and this could potentially
have changed the axis of rotation (and thus the line of pull for muscle
stretch and joint loading). It is possible that the stretched muscles in
stooped patients were more sensitive to axial torsion, providing
greater afferent feedback in the OFF condition. Similarly, medication
may have reduced axial muscle rigidity in PD patients. In the OFF state
when patients were more rigid, the externally applied axial rotation
may have required greater force, inducing greater pull on e.g. the skin.
This in turn could have provided patients with additional afferent
feedback, explaining why kinaesthesia falsely appeared to be better in
the OFF state. Indeed, it is likely that the experimental design used by
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the straps will likely provide cutaneous cues to the direction of the
pull, which can generate strong kinaesthetic sensations (Proske and
Gandevia, 2009).
Possible inﬂuence on clinical manifestations
Do these ﬁndings by Wright and colleagues have any clinical
relevance? The authors have demonstrated strong associations
between ON–OFF differences in kinaesthetic thresholds for passive
axial movements and functional impairments observed during the
OFF state. The results, while interesting, are not unexpected if one
considers that disease severity in the OFF state should be highly
correlated to ON–OFF changes in most PD symptoms, since patients
with the greatest functional impairments in the OFF state are likely
have the highest capacity for improvements from medication.
Therefore greater clinical insight could be gained in the future by
investigating the association between ON–OFF kinaesthetic differ-
ences in relation to ON–OFF changes in axial, PIGD and motor
symptoms, in order to determine which PD deﬁcits, including
dyskinesias (Zia et al., 2002), may be linked to medication-induced
changes in kinaesthesia.
Furthermore, the present experiment did not test axial kinaesthe-
sia and dynamic balance control in the same subjects, which is needed
when searching for a direct relationship. The same applies to a
possible correlation with falls in daily life. This should now be tested
in follow-up experiments. These should also test kinaesthesia in the
legs, and also examine hip or trunk kinaesthesia for other movement
directions that are associated with the greatest postural instability in
PD, in particular in the backward direction (Carpenter et al., 2004;
Dimitrova et al., 2004). In the next paragraphs, we will discuss a few
possible implications of the ﬁndings by Wright and colleagues.
Automatic postural reactions
Based on the available evidence, it actually seems unlikely that
axial kinaesthetic deﬁcits contribute to the abnormalities in automatic
postural reactions observed previously in PD. Certainly, propriocep-
tion is an important contributor to normal postural reactions elicited
by unexpected externally imposed perturbations. For example,
patients with distal sensory neuropathies have decreased amplitudes
of triggered postural responses (Bloem et al., 2000; Jauregui-Renaud
et al., 1998), while patients with proprioceptive loss of the proximal
joints additionally have markedly delayed postural reactions (Bloem
et al., 2002). If balance impairment in PD patients would be related to
a global loss in proprioception, then their postural responses would be
expected to be attenuated, and potentially delayed if proximal deﬁcits
are involved. However, PD patients have normal timing of postural
reactions, and in fact show excessive muscle activity in their auto-
matic balance reactions (Carpenter et al., 2004; Folkerts and
Njiokiktjien, 1972; Schieppati and Nardone, 1991; Scholz et al.,
1987). Furthermore, unlike kinaesthetic abnormalities, which appear
to be worsened by dopaminergic medication (Wright et al., 2010;
O'Suilleabhain et al., 2001), postural reactions are typically not
responsive to dopaminergic medications (Carpenter et al., 2004;
Bloem et al., 1996). Similarly, deep brain stimulation can improve
kinaesthesia in PD (Maschke et al., 2005), but provides a less
convincing improvement in postural reactions of PD patients (Visser
et al., 2008a; Maurer et al., 2003). Therefore, deﬁcits in the timing and
modulation of postural reactions in PD are unlikely to be caused by
abnormalities in kinaesthesia. However, abnormal processing of
proprioceptive feedback could affect the ability of patients to properly
adjust the gain of their postural responses to changing characteristics
of balance perturbations. This could explain the ﬁxed gain of postural
responses that underlies postural inﬂexibility in PD (Bloem et al.,
1995; Horak et al., 1992).Stooped posture
Deﬁcits in axial kinaesthesia could lead to abnormal posturing. For
example, in situations where the support surface is shifted from a
purely horizontal position, PD patients have difﬁculty re-orient
themselves to a vertical position without the aid of visual cues
(Vaugoyeau et al., 2007; Proctor et al., 1964). Because of their
defective axial kinaesthesia, patients might also falsely perceive their
subjective vertical to be shifted backward, forcing them to adopt a
stooped posture (Kitamura et al., 1993). Some evidence supports this
concept of incorrect trunk perception. In one experiment, patients
were confrontedwith line drawings showing varying degrees of stoop
and lateral deviation (Moore et al., 2000). When asked to identify the
drawing that best resembled their self-perceived posture, patients
were likely to underestimate the severity of their abnormalities. This
suggests that patients have lost their normal sense of trunk position in
space. This ﬁnding supplements clinical experience that many
patients are surprised to observe their own posture in a mirror.
Axial versus appendicular disability
Could deﬁcits in kinaesthesia explain previous observations that
suggested a differential therapeutic response of axial motor control
versus appendicular motor control (upper limb movements)? Indeed,
other investigators have reported a disconcordant therapeutic effect
on appendicular versus axial motor, in terms of both the beneﬁcial
treatment response and the adverse effects. We will discuss two
examples of a differential therapeutic response. The ﬁrst is a study
that examined the effect of STN stimulation on both appendicular
movements (reaching with the arms) and axial motor control
(walking) (Bastian et al., 2003). Unilateral stimulation improved
reaching, but not walking, for which bilateral stimulation was
required. The investigators suggested that the basal ganglia pathways
involved in control of walking and reaching may be distinct, and this
could perhaps also explain the differences in medication effects. The
second is a study from our lab, where we examined PD patients placed
on a multidirectionally moving support surface (Visser et al., 2008a).
The results showed that the protective arm movements responded
better to dopaminergic treatment than axial trunk control.
The adverse effects of treatment can also differ for axial and
appendicular motor control. For example, in a follow-up study of
patients with bilaterally implanted STN stimulators, we found that
many patients experienced a worsening of gait, despite a persistent
beneﬁcial effect on appendicular movements (van Nuenen et al.,
2008). Certainly, such ﬁndings would suggest that arm and trunk
movements may be served by dissociable neurophysiologic circuits
and dopaminergic pathways.
It would be logical to then speculate that dopaminergic medication
could speciﬁcally impair axial kinaesthesia, in the face of concurrent
beneﬁcial effects on limb control. However, this seems unlikely,
because kinaesthesia has also been found to be defective in the arms
of PD patients (Schneider et al., 1987; Zia et al., 2000; Maschke et al.,
2003; Konczak et al., 2007; Putzki et al., 2006; Fiorio et al., 2007;
O'Suilleabhain et al., 2001). Moreover, as pointed out earlier, deﬁcits
in limb kinaesthesia also predominate in the ON state (O'Suilleabhain
et al., 2001), similar to the ﬁndings of Wright et al. (2010) for the
trunk, so kinaesthesia seems equally impaired for axial and appen-
dicular movements.
Turning
It is obvious to speculate on the possibility that the rotational
kinaesthetic deﬁcits observed by Wright and colleagues may explain
the difﬁculties of PD patients in making yaw rotations (i.e. about their
longitudinal axis). This is clinically evident in early stages of the
disease, when patients experience difﬁculties turning around in bed
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(Bridgewater and Sharpe, 1998), and particularly when they try to
turn around in the standing position, even when straight walking is
still normal (Crenna et al., 2007). These turning movements while
standing are performed slowly (Visser and Voermans, 2007), with
small and abnormally timed steps (Huxham et al., 2008; Stack et al.,
2004) and ‘en bloc’ (i.e. without the normal multi-segmented axial
ﬂexibility) (Crenna et al., 2007; Vaugoyeau et al., 2006). Interestingly,
passively rotating PD patients in the yaw plane with their entire body
(by placing them on a rotating disk) is not abnormal (Earhart et al.,
2007), underscoring the importance of kinaesthetic deﬁcits occurring
at the level of the hips or trunks, as demonstrated by Wright and
colleagues.
The great relevance of these ﬁndings lies within the relation to falls
and injuries. Turning around the body's axis is the most important
cause for freezing of gait in PD (Schaafsma et al., 2003; Snijders et al.,
2008). In turn, freezing of gait is an important risk factor for falls in PD
(Latt et al., 2009; Kerr et al., 2010). Falls occurring while turning cause
the subject to fall sideways, and this is commonly associated with hip
fractures (Greenspan et al., 1998). And these hip fractures are
associated with considerable morbidity and even an increased
mortality in patients with PD, and are a leading reason for nursing
home admission (Idjadi et al., 2005; Coughlin and Templeton, 1980;
Eventon et al., 1983). So any therapeutic interventions that would
improve axial kinaesthesia could potentially have great beneﬁt for
patients with PD. In the next paragraph, wewill brieﬂy discuss several
therapeutic possibilities.
Consequences for treatment
It is too early to even speculate whether the ﬁndings of Wright
and colleagues should be a reason for concern about the use of
dopaminergic medication in PD. Cause or consequence could not
be differentiated in this study. While all patients used levodopa,
10 patients additionally used a dopamine receptor agonist, and a
few patients also used an anti-cholinergic, amantadine or selegi-
line. Therefore, it is impossible to pinpoint one class of drugs as
being potentially responsible for the observed changes in
kinaesthesia in ON compared to OFF states. Moreover, convincing
as the laboratory ﬁnding may have been, the Wright study did not
directly link the observed rotational kinaesthetic deﬁcits to
clinically relevant symptoms, such as the ability to turn while
walking, or the risk of falling. Obviously, such studies should now
be high on the research agenda. Until new ﬁndings arrive, it is
safe to state that the many great beneﬁts of dopaminergic
medication outweigh any theoretical risks about adverse effects
on axial kinaesthesia.
It also needs to be acknowledged that the reduced kinaesthesia in
the ON state may actually be considered beneﬁcial by the patients.
Perhaps untreated PD is characterised by a somatosensory integration
deﬁcit: kinaesthetic signals are being processed incorrectly due to
basal ganglia dysfunction (mainly within the globus pallidus), leading
to an abnormal body scheme (Filion et al., 1988). Sometimes it is
better to have no afferent feedback, instead of a ﬂawed feedback
signal. This scenario would predict that medication suppresses the
abnormal trunk signals, allowing patients to rely on other and more
reliable sources of feedback, such as vestibular signals which appear
to be processed normally – or even in an exaggerated way – in
patients with PD (Pastor et al., 1993).
Could stereotactic deep brain surgery (DBS) provide an alterna-
tive to medication? It is widely appreciated that the clinical effects
of DBS mimic those of dopaminergic medication, so any concerns
about drugs should also apply to surgery. However, one study
reported that DBS partially improved limb kinaesthesia (Maschke et
al., 2005), while another study found that DBS could restore
medication-induced reductions of short latency afferent inhibition(Sailer et al., 2007). More work is needed here, focusing on axial
kinaesthesia in larger patient groups, and also comparing different
surgical targets.
Finally, physiotherapy can be considered as a possible treatment to
correct or compensate for axial kinaesthetic deﬁcits. In the ﬁeld of
orthopaedics, randomised clinical trials have demonstrated beneﬁcial
effects of proprioceptive training (Lin et al., 2009; Liu-Ambrose et al.,
2003). However, the recently updated evidence-based guideline of
physiotherapy for PD does not include proprioceptive training as part
of the therapeutic arsenal that is supported by evidence or clinical
experience (Keus et al., 2009). Clearly, this now needs to be taken to
the test in properly designed studies.
Conclusion
The study by Wright and colleagues is important, as it draws
attention to the presence and possible importance of axial kinaes-
thetic deﬁcits for various clinically relevant symptoms in PD. The
results underscore that postural problems in PD can – at least to some
extent – be regarded as a proprioceptive disorder, next to the well-
known role played by motor deﬁcits. As any good study does, the
results of the Wright study also raised more questions than it
provided answers, offering an exciting menu of new research studies.
Taken together, this creates new hopes for patients and clinicians of
ﬁnding innovative solutions to treat this incapacitating disease.
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